A personalized approach with Prosigna.
New data where 2 out of 3 women with hormone positive breast cancer (HER2-negative) over 40 years of age, could safely skip chemotherapy thanks to the genetic test Prosigna. The survival rates were almost identical. This also included women who where higher risk such as stage 3 and with up to 9 positive lymph nodes.
https://www.tiktok.com/@drlemmocancer/video/7646924244118457607?lang=en
https://www.bbc.com/news/articles/c2325j0xk1vo
Discuss what this means for you
Research can raise useful questions. A study or individual case report does not establish that a treatment is suitable for everyone. Discuss medications, supplements and treatment changes with your care team.
Talk with our team